|
Abnova Corporation CEO Dr. Wilber Huang is invited to speak at Liquid Biopsy CTC Summit held in Xian, China. Dr. Huang’s speech highlights the clinical applications and prospects of captured Circulating Tumor Cells (CTCs).
Invited Speaker: Wilber Huang, MD Topic: Clinical Applications and Prospects of Circulating Tumor Cells Date: July 8th, 2017 Venue: Wyndham Hotel Xinxing Xian, China |
+886-2-87511888
sales@abnova.com
Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)